CS
Credit Suisse Portfolio holdings
AUM
$104B
This Quarter Return
+4.75%
1 Year Return
+34.55%
3 Year Return
+41.71%
5 Year Return
+124.92%
10 Year Return
+254.42%
AUM
$85.6B
AUM Growth
+$85.6B
(+8.5%)
Cap. Flow
+$2.32B
Cap. Flow
% of AUM
2.71%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
3,885
New
189
Increased
1,359
Reduced
1,744
Closed
350
Top Buys
| 1 |
Citigroup
C
|
$427M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$339M |
| 3 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
$315M |
| 4 |
Invesco QQQ Trust
QQQ
|
$236M |
| 5 |
Merck
MRK
|
$227M |
Top Sells
Sector Composition
| 1 | Technology | 14.88% |
| 2 | Financials | 14.5% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 8.88% |
| 5 | Industrials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Boeing
BA
$175B
| $302M | 0.27% |
1,024,772
+100,658
| +11% | +$29.7M |
|
52
Gilead Sciences
GILD
$140B
| $301M | 0.27% |
4,195,138
+102,055
| +2% | +$7.31M |
|
53
VanEck Junior Gold Miners ETF
GDXJ
$6.94B
| $291M | 0.26% |
8,516,697
+3,768,519
| +79% | +$129M |
|
54
Oracle
ORCL
$627B
| $291M | 0.26% |
6,146,416
+901,830
| +17% | +$42.6M |
|
55
Altria Group
MO
$111B
| $289M | 0.26% |
4,040,626
+71,943
| +2% | +$5.14M |
|
|
CDK
56
DELISTED
CDK Global, Inc.
CDK
| $288M | 0.26% |
4,034,697
+602,512
| +18% | +$42.9M |
|
57
EQT Corp
EQT
$32.1B
| $285M | 0.25% |
5,003,779
+3,037,355
| +154% | +$173M |
|
58
General Motors
GM
$55.6B
| $282M | 0.25% |
6,881,093
+4,405,228
| +178% | +$181M |
|
59
Nike
NKE
$111B
| $281M | 0.25% |
4,487,460
-379,973
| -8% | -$23.8M |
|
60
PepsiCo
PEP
$202B
| $275M | 0.25% |
2,296,495
-126,200
| -5% | -$15.1M |
|
61
Tesla
TSLA
$1.1T
| $272M | 0.24% |
875,067
+217,776
| +33% | +$67.8M |
|
62
Amgen
AMGN
$153B
| $257M | 0.23% |
1,480,005
-76,258
| -5% | -$13.3M |
|
63
Union Pacific
UNP
$130B
| $257M | 0.23% |
1,915,356
+256,553
| +15% | +$34.4M |
|
64
NVIDIA
NVDA
$4.16T
| $254M | 0.23% |
1,314,312
+73,474
| +6% | +$14.2M |
|
65
Grifois
GRFS
$6.61B
| $251M | 0.22% |
10,941,230
-529,967
| -5% | -$12.1M |
|
66
Schlumberger
SLB
$52.4B
| $246M | 0.22% |
3,655,473
+1,173,770
| +47% | +$79.1M |
|
67
Akamai
AKAM
$11.1B
| $244M | 0.22% |
3,746,196
+2,954,854
| +373% | +$192M |
|
68
Bristol-Myers Squibb
BMY
$96.8B
| $243M | 0.22% |
3,971,736
+75,055
| +2% | +$4.6M |
|
69
Mastercard
MA
$534B
| $236M | 0.21% |
1,557,279
-31,076
| -2% | -$4.7M |
|
70
Goldman Sachs
GS
$219B
| $235M | 0.21% |
923,036
+129,647
| +16% | +$33M |
|
71
Enterprise Products Partners
EPD
$68.9B
| $233M | 0.21% |
8,802,733
+2,588,146
| +42% | +$68.6M |
|
|
CELG
72
DELISTED
Celgene Corp
CELG
| $233M | 0.21% |
2,230,695
+297,148
| +15% | +$31M |
|
73
Deutsche Bank
DB
$66.7B
| $228M | 0.2% |
11,982,124
+1,908,698
| +19% | +$36.3M |
|
74
SPDR S&P 500 ETF Trust
SPY
$654B
| $228M | 0.2% |
852,876
-891,097
| -51% | -$238M |
|
75
Medtronic
MDT
$118B
| $220M | 0.2% |
2,719,822
+210,468
| +8% | +$17M |
|